The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis
Abstract
Introduction: Lymphangioleiomyomatosis (LAM) is a rare disease in women, leading to progressive deterioration of lung function and respiratory failure. We describe the outcome of patients with end-stage LAM who underwent lung transplantation at our center. Materials and Methods: The records of patients with LAM transplanted at our institution between February 1997 and May 2015 were reviewed retrospectively. Morbidity and mortality were analyzed, and actuarial survival was calculated using Kaplan-Meier methods. The cumulative survival of transplant patients with LAM at our center was compared with survival after transplantation due to different diseases at our center and the results of the International Society for Heart and Lung Transplantation. Quality of life was assessed by a patient self-report at the end of the first postoperative year. Results: During the study period, 25 patients underwent lung transplantation for LAM. All patients were women with a mean age of 50 (9) years. Thirteen patients (52%) had undergone previous thoracotomy. All patients (100%) received bilateral lung transplantation. One (4%) case of in-hospital mortality occurred and 9 (36%) late deaths. Two (8%) cases of late death were due to chronic lung allograft dysfunction. The 1-, 3-, and 5-year survival rates were 92%, 84%, and 76%, respectively. Quality-of-life ratings were above the normal in all eight 36-Item Short Form Health Survey subscales 1 year after transplantation. Conclusions: Lung transplantation offers a valuable therapy for patients with end-stage pulmonary LAM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fewer patients with LAM have required lung transplant since the standardized use of mTOR inhibitors as treatment, but it remains an indication for those with severely abnormal lung function (FEV1 < 30%), exertional dyspnea (NYHA class III or IV), or hypoxemia at rest.(303–306, 308–315)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [308]
Citations
Cites
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
Sengupta, S., Peterson, T. R., & Sabatini, D. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.026 · Cited by 1,241
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100391 · Cited by 1,099
Yusen, R. D., Edwards, L. B., Dipchand, A. I., Goldfarb, S. B., Kucheryavaya, A. Y., Levvey, B. J., Lund, L. H., Meiser, B., Rossano, J. W., & Stehlik, J. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.09.001 · Cited by 596
The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 Patients at Enrollment
Ryu, J. H., Moss, J., Beck, G. J., Lee, J.-C., Brown, K. K., Chapman, J. T., Finlay, G. A., Olson, E. J., Ruoss, S. J., Maurer, J. R., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1298oc · Cited by 468
Kitaichi, M., Nishimura, K., Itoh, H., & Izumi, T. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.2.7842216 · Cited by 362
Pulmonary Lymphangioleiomyomatosis: A Study of 69 Patients
Urban, T., Lazor, R., Lacronique, J., Murris, M., Labrune, S., & Valeyre, D. (1999) · Medicine · doi:10.1097/00005792-199909000-00004 · Cited by 329
FRANZ, D. N., BRODY, A., MEYER, C., LEONARD, J., CHUCK, G., DABORA, S., SETHURAMAN, G., COLBY, T. V., KWIATKOWSKI, D. J., & Mc CORMACK, F. X. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2011025 · Cited by 287
King-Biggs, M. B., Dunitz, J. M., Park, S. J., Kay Savik, S., & Hertz, M. I. (2003) · Transplantation · doi:10.1097/01.tp.0000064083.02120.2c · Cited by 210
Harknett, E. C., Chang, W. Y. C., Byrnes, S., Johnson, J., Lazor, R., Cohen, M. M., Gray, B., Geiling, S., Telford, H., Tattersfield, A. E., et al. (2011) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcr116 · Cited by 185
Primary Graft Dysfunction: Definition, Risk Factors, Short- and Long-Term Outcomes
Lee, J., Christie, J. D., & Keshavjee, S. H. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1249111 · Cited by 147
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Elia, D., Torre, O., Cassandro, R., Caminati, A., & Harari, S. A. (2020) · European Respiratory Review · doi:10.1183/16000617.0163-2019 · Cited by 21
French recommendations for the diagnosis and management of lymphangioleiomyomatosis
Cottin, V., Blanchard, É., Kerjouan, M., Lazor, R., Reynaud‐Gaubert, M., Taillé, C., Uzunhan, Y., Wémeau-Stervinou, L., Andréjak, C., Baud, D., et al. (2023) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2023.101010 · Cited by 24
Lung transplantation for lymphangioleiomyomatosis
Warrior, K., & Dilling, D. F. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.09.021 · Cited by 15
Zhang, J., Liu, D., Yue, B., Ban, L., Zhou, M., Wang, H., Lv, J., Wu, B., Zhai, Z., Xu, K., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.584826 · Cited by 11
Metadata
- Authors
- Salman, J., Ius, F., Sommer, W., Siemeni, T., Fleissner, F., Alhadidi, H., Kugler, C., Avsar, M., Haverich, A., Warnecke, G., Tudorache, I., & Kuhn, C.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- King Hussein Medical Center (JO)
- Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany
- Corresponding author
- Salman, Jawad
- ORCID
- Venue
- Progress in Transplantation
- Publisher
- SAGE Publications
- Published
- 2019-05-13
- Volume
- 29
- Issue
- 2
- Pages
- 115-121
- ISSN
- 0905-9199 (ISSN-L)
- 1526-9248
- 2164-6708
- OpenAlex
- W2945670056
- Semantic Scholar
- 198905db13c68acd7c1158af19a4b6ec70a2aa92
- Cited by
- 15
- References
- 23
- Citations by year
- 2026: 1 · 2023: 7 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Progress in Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- lymphangioleiomyomatosis, lung transplantation, bilateral lung transplantation, end-stage lung disease, long-term survival, chronic lung allograft dysfunction, quality of life, respiratory failure, thoracotomy
- MeSH terms
- Female, Germany, Humans, Lung Neoplasms, Middle Aged, Quality of Life, Retrospective Studies, Survival Rate, Lung Transplantation, Treatment Outcome, Lymphangioleiomyomatosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. https://app.cochat.ai/papers/10.1177/1526924819835815
- The paper
- Salman, J., Ius, F., Sommer, W., Siemeni, T., Fleissner, F., Alhadidi, H., Kugler, C., Avsar, M., Haverich, A., Warnecke, G., Tudorache, I., & Kuhn, C. (2019). Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. Progress in Transplantation. https://doi.org/10.1177/1526924819835815
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.